About ATXA Therapeutics Limited
Headquartered in Dublin, Ireland, ATXA Therapeutics is developing novel therapies for the treatment of Pulmonary Arterial Hypertension (PAH), along with other cardiopulmonary and related disease indications.
Headquartered in Dublin, Ireland, ATXA Therapeutics is developing novel therapies for the treatment of Pulmonary Arterial Hypertension (PAH), along with other cardiopulmonary and related disease indications.